Protagenic Therapeutics, Inc. Business Finance Contracts & Agreements
63 Contracts & Agreements
- Exchange Agreements (2 contracts)
- Guaranty Agreements (2)
- Modification Agreements (1)
- Note Agreements (20)
- Purchase Agreements (6)
- Registration Rights Agreements (3)
- Release Agreements (2)
- Security Agreements (2)
- Stock Agreements (7)
- Underwriting Agreements (2)
- Warrant Agreements (16)
- Form of Registration Rights Agreement (Filed With SEC on October 30, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on October 30, 2024)
- Form of Placement Agent Warrant (Filed With SEC on October 30, 2024)
- Form of Series B Common Stock Purchase Warrant (Filed With SEC on October 30, 2024)
- Form of Series A Common Stock Purchase Warrant (Filed With SEC on October 30, 2024)
- 5.00% Promissory Note (Filed With SEC on May 17, 2021)
- Underwriting Agreement dated April 26, 2021, by and among the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc,as representative of the underwriters (Filed With SEC on April 30, 2021)
- Form of Warrant (included in Exhibit 10.15) (Filed With SEC on April 26, 2021)
- Form of Warrant (included in Exhibit 10.15) (Filed With SEC on April 23, 2021)
- Form of Warrant (included in Exhibit 10.15) (Filed With SEC on April 9, 2021)
- Form of Underwriting Agreement (Filed With SEC on April 9, 2021)
- Form of Guaranty (Filed With SEC on November 21, 2019)
- Form of Convertible Promissory Note (Filed With SEC on November 21, 2019)
- Form of Convertible Note Purchase Agreement (Filed With SEC on November 21, 2019)
- NONQUALIFIED STOCK OPTION GRANT AGREEMENT PROTAGENIC THERAPEUTICS, INC. (Filed With SEC on June 20, 2016)
- RegistrationRights Agreement (Filed With SEC on April 18, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on April 18, 2016)
- FORM OF BROKERS WARRANT (Filed With SEC on April 18, 2016)
- NOTE (Filed With SEC on February 12, 2016)
- AMENDED AND RESTATED NOTE (Filed With SEC on February 12, 2016)
- STOCK PURCHASE AGREEMENT (Filed With SEC on February 12, 2016)
- PROTAGENIC THERAPEUTICS,INC. FORM OF NONQUALIFIED STOCK OPTION AGREEMENT (2006 Stock Plan) (Filed With SEC on February 12, 2016)
- PROTAGENIC THERAPEUTICS, INC. FORM OF 2006 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN (Filed With SEC on February 12, 2016)
- PREFERRED STOCK EXCHANGE AGREEMENT (Filed With SEC on February 12, 2016)
- INVESTOR NOTE EXCHANGE AGREEMENT (Filed With SEC on February 12, 2016)
- GENERAL RELEASE AGREEMENT (Filed With SEC on February 12, 2016)
- GENERAL RELEASE AGREEMENT (Filed With SEC on February 12, 2016)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on February 12, 2016)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on February 12, 2016)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on February 12, 2016)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on February 12, 2016)
- WARRANT TO PURCHASE SHARES OF SERIES B PREFERRED STOCK OR COMMON STOCK (Filed With SEC on February 12, 2016)
- WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on February 12, 2016)
- SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 5, 2016)
- SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on February 5, 2016)
- SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 2, 2015)
- SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on November 2, 2015)
- Note Modification Agreement (Filed With SEC on September 9, 2015)
- Note Modification Agreement (Filed With SEC on September 9, 2015)
- SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 9, 2015)
